Ironwood Pharmaceuticals | 债务利息支出



金融业
股票价格
USD
资产
USD 396.06M
现金及等价物
USD 140.41M
销售成本
USD 29.83M
流动资产
USD 273.84M
流动负债
USD 242.5M
债务
USD 583.99M
EBIT
USD 33.22M
EBITDA
USD 81.81M
员工
267
EPS每股收益
USD -0.01
股本和储备
USD -264.16M
销售毛利
USD 85.24M
债务利息支出
USD 8.74M
利息收入
USD 778K
贷款资金
USD 583.99M
市值
USD 535.3M
净收入
USD 3.19M
营业费用
USD 57.33M
营业利润
USD 33.22M
普通股股本
USD 160K
PE价格收益
USD 204.24
税前利润
USD 68.02M
销售收入
USD 47.71M
销售和管理费用
USD 33.33M
贸易债权人
USD 1.61M
应收帐款人
USD 81.89M


债务利息支出 更改 日
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Akebia Therapeutics 364.15M 18.56M 2025-09
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amarin USD 3K 5K 2024-12
Ardelyx USD 5.8M 784K 2025-09
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Charles River Laboratories USD 23.78M 1.63M 2025-12
Coherus Biosciences USD 2.15M 3.2M 2025-03
Esperion Therapeutics USD 15.08M 1.36M 2024-09
Exact Sciences USD 9.79M 46K 2025-09
Halozyme Therapeutics USD 4.91M 615K 2025-12
Incyte USD 582K 10K 2025-12
Ironwood Pharmaceuticals USD 8.74M 506K 2024-12
Karyopharm Therapeutics USD 11.38M 2.43M 2024-09
Lexicon Pharmaceuticals USD 2.21M 2.74M 2024-06
MacroGenics USD 3.34M 2.54M 2025-09
Moderna USD 12.14B 12.13B 2025-09
Myriad Genetics USD 800K 100K 2025-03
Pacira USD 3.89M 387K 2025-12
PTC Therapeutics USD 50.58M 2.59B 2025-12
Puma Biotechnology USD 3.37M 11K 2024-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Takeda JPY 123.63B 40.49B 2025-12
Ultragenyx Pharmaceutical USD 19M 4.85M 2025-12
Vanda Pharmaceuticals 601.14M 23.61M 2025-09


Ironwood Pharmaceuticals 债务利息支出 - 当前值，历史数据，预测，统计，图表和经济日历 - Mar 2026.